Literature DB >> 9536661

Dose-related proconvulsant and anticonvulsant activity of isatin, a putative biological factor, in rats.

S K Bhattacharya1, A Chakrabarti.   

Abstract

Isatin (indole-2, 3-dione) is an endogenous compound with anxiogenic properties, which occur within a narrow dose range (15-20 mg/kg, i.p.). Dose increment beyond 50 mg/kg, i.p. leads to the loss of anxiogenesis. Since a link has been postulated between anxiogenic and convulsant activity, the effect of a range of doses of isatin (20-80 mg/kg, i.p.) was investigated on subconvulsant and convulsant doses of two seizure-inducing agents, namely, pentylenetetrazole (PTZ) and 3-mercapto-propionic acid (3MPA) in rats. Isatin was found to induce a dose-related effect on PTZ and 3MPA convulsions. The lower dose (20 mg/kg, i.p.) potentiated PTZ and 3MPA convulsions, a median dose (40 mg/kg, i.p.) had insignificant effect, whereas higher doses (60 and 80 mg/kg, i.p.) of isatin exhibited significant anticonvulsant effect against both PTZ and 3MPA induced clonic convulsions. The investigation, thus, supports the contention that anxiogenic agents increase the susceptibility to chemical seizures. The proconvulsant effect of isatin, may be due to its inhibitory effect on central atrial natriuretic peptide receptors and stimulation of 5-hydroxytryptamine3 (5-HT3) rather than its monoamine oxidase (MAO) B inhibitory action. The anticonvulsant effect on higher doses of isatin, on the contrary, may be induced by its metabolites, including 5-hydroxyisatin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9536661

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  15 in total

1.  QM study and conformational analysis of an isatin Schiff base as a potential cytotoxic agent.

Authors:  Ramin Miri; Nima Razzaghi-asl; Mohammad K Mohammadi
Journal:  J Mol Model       Date:  2012-09-29       Impact factor: 1.810

Review 2.  Tryptophan Metabolites as Mediators of Microbiota-Gut-Brain Communication: Focus on Isatin.

Authors:  Alexei Medvedev; Olga Buneeva
Journal:  Front Behav Neurosci       Date:  2022-06-30       Impact factor: 3.617

3.  2-(5-Fluoro-2,3-dioxoindolin-1-yl)ethyl 4-methyl-piperazine-1-carbodithio-ate.

Authors:  Yao Wang; Hui-Hui Lin; Sheng-Li Cao
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-12-10

4.  Synthesis, characterization, and analgesic activity of novel schiff base of isatin derivatives.

Authors:  Rajaram Prakash Chinnasamy; Raja Sundararajan; Saravanan Govindaraj
Journal:  J Adv Pharm Technol Res       Date:  2010-07

5.  Isatin Counteracts Diethylnitrosamine/2-Acetylaminofluorene-Induced Hepatocarcinogenesis in Male Wistar Rats by Upregulating Anti-Inflammatory, Antioxidant, and Detoxification Pathways.

Authors:  Nagwa G Tawfik; Wafaa R Mohamed; Hanan S Mahmoud; Mohammed A Alqarni; Ibrahim A Naguib; Alzhraa M Fahmy; Osama M Ahmed
Journal:  Antioxidants (Basel)       Date:  2022-04-01

Review 6.  Are the Traditional Medical Uses of Muricidae Molluscs Substantiated by Their Pharmacological Properties and Bioactive Compounds?

Authors:  Kirsten Benkendorff; David Rudd; Bijayalakshmi Devi Nongmaithem; Lei Liu; Fiona Young; Vicki Edwards; Cathy Avila; Catherine A Abbott
Journal:  Mar Drugs       Date:  2015-08-18       Impact factor: 5.118

7.  2-(2-Fluoro-4-hy-droxy-benz-yl)isoindoline-1,3-dione.

Authors:  Hilal Vesek; Canan Kazak; Ayşen Alaman Ağar; Sümeyye Gümüş; Muhittin Aygün
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-07-18

8.  Crystal structure of 3-methyl-pyridinium picrate: a triclinic polymorph.

Authors:  Jeganathan Gomathi; Doraisamyraja Kalaivani
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-09-17

9.  Synthesis, potential anticonvulsant and antidepressant effects of 2-(5-methyl-2,3-dioxoindolin-1-yl)acetamide derivatives.

Authors:  Xinghua Zhen; Zhou Peng; Shuilian Zhao; Yan Han; Qinghao Jin; Liping Guan
Journal:  Acta Pharm Sin B       Date:  2015-03-18       Impact factor: 11.413

10.  A Neuroprotective Dose of Isatin Causes Multilevel Changes Involving the Brain Proteome: Prospects for Further Research.

Authors:  Alexei Medvedev; Arthur Kopylov; Olga Buneeva; Leonid Kurbatov; Olga Tikhonova; Alexis Ivanov; Victor Zgoda
Journal:  Int J Mol Sci       Date:  2020-06-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.